Your browser doesn't support javascript.
loading
Targeting TRAF3IP2 inhibits angiogenesis in glioblastoma.
Izadpanah, Amin; Daneshimehr, Fatemeh; Willingham, Kurtis; Barabadi, Zahra; Braun, Stephen E; Dumont, Aaron; Mostany, Ricardo; Chandrasekar, Bysani; Alt, Eckhard U; Izadpanah, Reza.
Afiliación
  • Izadpanah A; Applied Stem Cell Laboratory, Medicine/Heart and Vascular Institute, Tulane University School of Medicine, New Orleans, LA, United States.
  • Daneshimehr F; Applied Stem Cell Laboratory, Medicine/Heart and Vascular Institute, Tulane University School of Medicine, New Orleans, LA, United States.
  • Willingham K; Applied Stem Cell Laboratory, Medicine/Heart and Vascular Institute, Tulane University School of Medicine, New Orleans, LA, United States.
  • Barabadi Z; Applied Stem Cell Laboratory, Medicine/Heart and Vascular Institute, Tulane University School of Medicine, New Orleans, LA, United States.
  • Braun SE; Division of Regenerative Medicine, Tulane National Primate Research Center, Covington, LA, United States.
  • Dumont A; Department of Neurosurgery, Tulane University School of Medicine, New Orleans, LA, United States.
  • Mostany R; Department of Pharmacology, Tulane University School of Medicine, New Orleans, LA, United States.
  • Chandrasekar B; Department of Medicine, University of Missouri School of Medicine and Harry S. Truman Veterans Memorial Hospital, Columbia, MO, United States.
  • Alt EU; Applied Stem Cell Laboratory, Medicine/Heart and Vascular Institute, Tulane University School of Medicine, New Orleans, LA, United States.
  • Izadpanah R; Department of Medicine, Isarklinikum Munich, Munich, Germany.
Front Oncol ; 12: 893820, 2022.
Article en En | MEDLINE | ID: mdl-36046049

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos